More PRNewswire
View Older Stories View Newer Stories-
Somite Therapeutics and OmniaBio Inc. Announce Collaboration to Advance Somite's Cell Therapy Flagship Program
-
First Citizens Bank Serves as Co-Lead Arranger on $300 Million Credit Facility for Swift Current Energy
-
Collective Voice Report: Brands and Creators Should Rethink Their Content Strategy in the Election Season
-
Natural Grocers® Announces Collaboration with Bitchin' Sauce to Benefit the Natural Grocers Heroes in Aprons Fund
-
Vyne Dental Named Quarterfinalist in 2024 Digital Health Hub Foundation Awards
-
Domino's® is Saying No to Shrinkflation by Launching MOREflation
-
GENERATIONAL DIVIDE EMERGING ON INTERNATIONAL EDUCATION, HSBC DATA FINDS
-
Sport facility in The Hague heated by the local sewer
-
Taylor Morrison and Extreme Makeover: Home Edition to Film in Phoenix and Support Local, Deserving Families and Cancer Patients
-
BIZCLIK MEDIA LAUNCHES SEPTEMBER EDITIONS OF TECHNOLOGY, AI & MOBILE MAGAZINES
-
RedHill's Talicia® Listed as First-Line Choice for H. pylori in New American College of Gastroenterology Guidelines
-
Siyata Mobile to Showcase PTT Solutions at EMS World Expo September 9 - 13
-
SystImmune, Inc. to Present New BL-B01D1 Data in Urothelial, Biliary Tract, and Esophageal Squamous Cell Carcinoma at ESMO Congress 2024
-
LogicSource and Cleveland Clinic Collaborate to Help Health Systems with Non-Clinical Procurement Practices and Benchmarking
-
G Mining Ventures Delivers PEA for High-Grade Oko West Gold Project in Guyana
-
Aurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo CBD lozenge
-
Compugen to Present at Single Cell Genomics 2024 Conference
-
ZIM Announces New Operational Cooperation with MSC Covering the Strategic Transpacific Trade
-
B. Riley Financial Provides Update on Strategic and Financing Initiatives
-
Veren Announces Strategic Infrastructure Transaction
-
FDA Issues 'Letter of Support' Encouraging Use of Synuclein-based Biomarker, αSyn-SAA, in Clinical Trials in Parkinson's and Related Diseases
-
Breaking the silence on menopause. More than half of women 40+ say they have experienced a change in the appearance of their teeth or gums as they age
-
Gryphon Investors Closes Continuation Vehicle for Vessco Water
-
Iris and Telycam Join Forces to Deliver Unprecedented Cloud-Based Camera Control
-
Canadian Medical Technology Consortium Collaborates on State-of-the-Art Postoperative Patient Management Platform, Led by FluidAI
-
FalconPoint Partners Appoints Adam Gross as Partner, Head of Business Development and Capital Markets
-
Aircastle Appoints David Odlum as Chief Risk Officer
-
Nanoscope Therapeutics Announces Presentations at the Retina Society and Advanced Therapies Europe Annual Meetings in Lisbon
-
TELYNET USA LLC: We Are Now Operating in the U.S. Market!
-
The Cigna Group's "Community Vitality Project" Donates $75,000 to Nonprofits through Program Encouraging Fitness and Community Engagement
-
Welltower to Participate in the BofA Securities 2024 Global Real Estate Conference
-
Achieve closes $263.3 million, AAA-rated personal loan securitization
-
Alithya to co-present with McKesson at Oracle CloudWorld 2024
-
Swift Current Energy Secures $300 Million Facility to Support Renewable Energy Portfolio Buildout
-
Blue Faery Continues Its Love Your Liver Campaign During Hispanic Heritage Month
-
SportsGrid Expands Content Offering with Brian Christopher Partnership
-
PERC Announces Pioneering Research Combining CO2, Wind and Solar to Produce Propane with Below-Zero Carbon Intensity
-
Target Announces Limited-Edition Collection for Pets and Pet Lovers
-
WellSync and Marius Pharmaceuticals Collaborate to Offer FDA-approved Oral Testosterone Replacement Therapy, Expanding Virtual Care for Men's Health
-
Sinch announces changes to its financial leverage policy
-
Beijing, Where Events Come Alive!
-
Lilly appoints Lucas Montarce as executive vice president and chief financial officer
-
UniFirst celebrates grand opening of state-of-the-art uniform service and processing facility in London, Ontario
-
Updated Data for Nuvalent's ALK-Selective Inhibitor, NVL-655, and ROS1-Selective Inhibitor, Zidesamtinib, Continue to Support Potential Best-in-Class Profiles
-
GoldMining Discovers Gold and Copper Mineralization in Drilling 1 km from the São Jorge Deposit, Brazil
-
NEW GOLD STRENGTHENS BOARD WITH SEASONED APPOINTMENTS
-
AT&T Strengthens Fiber Leadership with Plans to Bring High-Speed Internet to More People Through New and Expanded Third-Party Relationships
-
Drut Technologies Delivers Virtual Disaggregation for GPU Servers
-
Chipsea Charts a Path for Strategic Expansion Through Enhanced Computing Peripherals
-
Pearle Vision Announces Return of Dr. Pearle Scholarship Program
